Skip to main content
logo
ME Therapeutics Holdings Inc. (CSE:METX)
Canada flag Canada · Delayed Price · Currency is CAD
2.150
+0.650 (43.33%)
At close: Aug 28, 2026

ME Therapeutics Holdings Ratios and Metrics

Millions CAD. Fiscal year is Sep - Aug.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Market Capitalization
6511869---
Market Cap Growth
-41.89%70.86%----
Enterprise Value
6511768---
Last Close Price
2.154.002.75---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
PB Ratio
101.2878.7446.94---
P/TBV Ratio
101.2878.7446.94---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Debt / Equity Ratio
0.040.05-0.08-1.46-3.40
Debt / FCF Ratio
-----17.86
Net Debt / Equity Ratio
-0.79-0.89-1.01-1.16-0.880.74
Net Debt / EBITDA Ratio
0.331.071.090.62-0.760.19
Net Debt / FCF Ratio
0.401.232.282.00-0.85-3.89
Quick Ratio
3.876.0024.054.410.572.27
Current Ratio
3.916.1224.454.520.592.27
Return on Equity (ROE)
-111.03%-80.11%-129.52%-3327.53%--2126.14%
Return on Assets (ROA)
-69.00%-48.35%-77.65%-157.78%-106.78%-60.78%
Return on Capital Employed (ROCE)
-240.40%-84.30%-93.10%-186.70%212.60%-167.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Earnings Yield
-2.11%-1.01%-1.87%---
FCF Yield
-1.97%-0.91%-0.95%---
Buyback Yield / Dilution
-11.85%-14.17%-55.90%-84.08%-39.53%-0.07%